Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy

By Khatami Ali   Hugosson Jonas   Wang Wanzhong   Damber Jan-Erik  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 1, 2009-02 ,pp. : 12-18

Informa Healthcare

Access to resources Recommend Favorite

Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy

By Yang X.J.   Lecksell K.   Potter S.R.   Epstein J.I.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 528-532

Elsevier

Access to resources Recommend Favorite

Gleason score 7 prostate cancer: a heterogeneous entity? correlation with pathologic parameters and disease-free survival

By Sakr W.A.   Tefilli M.V.   Grignon D.J.   Banerjee M.   Dey J.   Gheiler E.L.   Tiguert R.   Powell I.J.   Wood D.P.  

Urology, Vol. 56, Iss. 5, 2000-11 ,pp. : 730-734

Elsevier

Access to resources Recommend Favorite

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

By Merrick G.S.   Butler W.M.   Galbreath R.W.   Lief J.H.   Adamovich E.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 98-103

Elsevier

Access to resources Recommend Favorite

Should HIV patients be considered a high risk group for the development of prostate cancer?

By Quatan Nadine   Nair Sabarinath   Harrowes Fran   Hay Phillip  

Annals of The Royal College of Surgeons of England, Vol. 87, Iss. 6, 2005-11 ,pp. : 437-438

The Royal College of Surgeons of England

Access to resources Recommend Favorite